Sarepta has stopped developing SRP-5051, its exon 51-skipping therapy for Duchenne MD, due to long-term safety concerns and ...
The FDA has given the green light to a clinical trial testing ATA-200, a gene therapy for limb-girdle muscular dystrophy ...
Columnist Betty Vertin hopes her family's experience with kidney stones might help you be better prepared while living with DMD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback